XSB2942 : Cellular tumor antigen p53
[ CaMP Format ]
This entry is computationally expanded from SB0053
* Basic Information
Organism | Homo sapiens (human) |
Protein Names | Tumor suppressor p53; Phosphoprotein p53; Antigen NY-CO-13 |
Gene Names | P53 |
Gene Locus | Not available |
GO Function | Not available |
* Information From OMIM
Not Available.
* Structure Information
1. Primary Information
Length: 393 aa
Average Mass: 43.712 kDa
Monoisotopic Mass: 43.684 kDa
2. Domain Information
Annotated Domains: interpro / pfam / smart / prosite
Computationally Assigned Domains (Pfam+HMMER):
domain name | begin | end | score | e-value |
---|---|---|---|---|
P53_TAD 1. | 5 | 29 | 46.4 | 1.1e-10 |
--- cleavage 25 (inside P53_TAD 5..29) --- | ||||
P53 1. | 95 | 289 | 511.1 | 1.4e-150 |
P53_tetramer 1. | 318 | 359 | 85.5 | 1.9e-22 |
3. Sequence Information
Fasta Sequence: XSB2942.fasta
Amino Acid Sequence and Secondary Structures (PsiPred):
4. 3D Information
Known Structures in PDB: 1A1U (NMR; -; A/C=324-358), 1AIE (X-ray; 150 A; A=326-356), 1C26 (X-ray; 170 A; A=325-356), 1DT7 (NMR; -; X/Y=367-388), 1GZH (X-ray; 260 A; A=95-292, C=95-292), 1H26 (X-ray; 224 A; E=376-386), 1HS5 (NMR; -; A/B=324-357), 1JSP (NMR; -; A=367-386), 1KZY (X-ray; 250 A; A/B=95-289), 1MA3 (X-ray; 200 A; B=372-389), 1OLG (NMR; -; A/B/C/D=319-360), 1OLH (NMR; -; A/B/C/D=319-360), 1PES (NMR; -; A/B/C/D=325-355), 1PET (NMR; -; A/B/C/D=325-355), 1SAE (NMR; -; A/B/C/D=319-360), 1SAF (NMR; -; A/B/C/D=319-360), 1SAH (NMR; -; A/B/C/D=319-360), 1SAJ (NMR; -; A/B/C/D=319-360), 1SAK (NMR; -; A/B/C/D=319-360), 1SAL (NMR; -; A/B/C/D=319-360), 1TSR (X-ray; 220 A; A/B/C=94-312), 1TUP (X-ray; 220 A; A/B/C=94-312), 1UOL (X-ray; 190 A; A/B=94-312), 1XQH (X-ray; 175 A; B/F=369-377), 1YC5 (X-ray; 140 A; B=372-389), 1YCQ (X-ray; 230 A; B=13-29), 1YCR (X-ray; 260 A; B=15-29), 1YCS (X-ray; 220 A; A=94-292), 2AC0 (X-ray; 180 A; A/B/C/D=94-293), 2ADY (X-ray; 250 A; A/B=94-293), 2AHI (X-ray; 185 A; A/B/C/D=94-293), 2ATA (X-ray; 220 A; A/B/C/D=94-293), 2B3G (X-ray; 160 A; B=33-60), 2BIM (X-ray; 198 A; A/B=94-312), 2BIN (X-ray; 190 A; A=94-312), 2BIO (X-ray; 190 A; A=94-312), 2BIP (X-ray; 180 A; A=94-312), 2BIQ (X-ray; 180 A; A=94-312), 2F1X (X-ray; 230 A; A/B=360-368), 2FEJ (NMR; -; A=94-297), 2FOJ (X-ray; 160 A; B=363-367), 2FOO (X-ray; 220 A; B=358-363), 2GS0 (NMR; -; B=20-71), 2H1L (X-ray; 316 A; M/N/O/P/Q/R/S/T/U/V/W/X=92-292), 2H2D (X-ray; 170 A; B=372-389), 2H2F (X-ray; 220 A; B=372-389), 2H4F (X-ray; 200 A; D=372-389), 2H4H (X-ray; 199 A; B=372-389), 2H4J (X-ray; 210 A; D=372-389), 2H59 (X-ray; 190 A; D/E=372-389), 2J0Z (NMR; -; A/B/C/D=326-356), 2J10 (NMR; -; A/B/C/D=326-356), 2J11 (NMR; -; A/B/C/D=332-356), 2J1W (X-ray; 180 A; A/B=94-312), 2J1X (X-ray; 165 A; A/B=94-312), 2J1Y (X-ray; 169 A; A/B/C/D=94-293), 2J1Z (X-ray; 180 A; A/B=94-312), 2J20 (X-ray; 180 A; A/B=94-312), 2J21 (X-ray; 160 A; A/B=94-312), 2K8F (NMR; -; B=1-39), 2OCJ (X-ray; 205 A; A/B/C/D=94-312), 2PCX (X-ray; 154 A; A=94-292), 2QVQ (X-ray; 200 A; A=94-289), 2QXA (X-ray; 150 A; A/B/C/D=95-289), 2QXB (X-ray; 250 A; A/B/C/D=95-289), 2QXC (X-ray; 185 A; A/B/C/D=95-289), 2VUK (X-ray; 150 A; A/B=94-312), 2Z5S (X-ray; 230 A; P/Q/R=15-29), 2Z5T (X-ray; 230 A; P/Q/R=15-29), 3D05 (X-ray; 170 A; A=94-293), 3D06 (X-ray; 120 A; A=94-293), 3D07 (X-ray; 220 A; A/B=94-293), 3D08 (X-ray; 140 A; A=94-293), 3D09 (X-ray; 190 A; A=94-293), 3D0A (X-ray; 180 A; A/B/C/D=94-293), 3DAB (X-ray; 190 A; B/D/F/H=15-29), 3DAC (X-ray; 180 A; B/P=17-37), 3SAK (NMR; -; A/B/C/D=319-360)
* Cleavage Information
1 [sites]
Cleavage sites (±10aa)
[Site 1] QETFSDLWKL25-LPENNVLSPL
Leu25 Leu
P10 | P9 | P8 | P7 | P6 | P5 | P4 | P3 | P2 | P1 |
---|---|---|---|---|---|---|---|---|---|
Gln16 | Glu17 | Thr18 | Phe19 | Ser20 | Asp21 | Leu22 | Trp23 | Lys24 | Leu25 |
P1' | P2' | P3' | P4' | P5' | P6' | P7' | P8' | P9' | P10' |
Leu26 | Pro27 | Glu28 | Asn29 | Asn30 | Val31 | Leu32 | Ser33 | Pro34 | Leu35 |
Sequence conservation (by blast) Sequence conservation (by blast)
Reference peptide (cleaved bond±30 residues) |
---|
MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFT |
Summary
# | organism | max score | hits | top seq |
---|---|---|---|---|
1 | Homo sapiens | 117.00 | 44 | tumor protein p53 (Li-Fraumeni syndrome) |
2 | N/A | 117.00 | 14 | - |
3 | Pan troglodytes | 117.00 | 5 | PREDICTED: tumor protein p53 isoform 3 |
4 | synthetic construct | 117.00 | 3 | tumor protein p53 (Li-Fraumeni syndrome) |
5 | Tupaia belangeri chinensis | 117.00 | 1 | P53_TUPGB Cellular tumor antigen p53 (Tumor suppre |
6 | Macaca mulatta | 110.00 | 2 | tumor protein p53 |
7 | Chlorocebus aethiops | 110.00 | 1 | P53_CERAE Cellular tumor antigen p53 (Tumor suppre |
8 | Macaca fascicularis | 108.00 | 1 | P53 |
9 | Marmota monax | 89.40 | 1 | P53_MARMO Cellular tumor antigen p53 (Tumor suppre |
10 | Spalax judaei | 83.60 | 1 | p53 protein |
11 | Cavia porcellus | 82.40 | 1 | P53_CAVPO Cellular tumor antigen p53 (Tumor suppre |
12 | Delphinapterus leucas | 80.50 | 1 | P53_DELLE Cellular tumor antigen p53 (Tumor suppre |
13 | Meriones unguiculatus | 72.40 | 1 | p53 |
14 | Oryctolagus cuniculus | 71.20 | 1 | tumor protein p53 |
15 | Cricetulus griseus | 69.70 | 2 | p53 tumour suppressor |
16 | Mesocricetus auratus | 69.70 | 1 | tumor supressor p53 |
17 | Sus scrofa | 68.20 | 3 | tumor suppressor p53 |
18 | Ovis aries | 67.80 | 1 | P53 protein |
19 | Canis familiaris | 67.80 | 1 | P53 |
20 | Felis catus | 66.20 | 2 | tumor protein p53 |
21 | Canis lupus familiaris | 65.90 | 1 | tumor protein p53 |
22 | Bos taurus | 64.30 | 2 | p53 |
23 | Mus musculus | 61.60 | 12 | transformation related protein 53 |
24 | Rattus norvegicus | 52.00 | 5 | tumor protein p53 |
25 | Bos primigenius | 50.40 | 1 | p53 gene product |
26 | Mastomys natalensis | 47.00 | 1 | p53 |
27 | Xenopus tropicalis | 44.70 | 1 | tumor protein p53 (Li-Fraumeni syndrome) |
28 | Xenopus laevis | 43.50 | 5 | tumor suppressor protein p53 |
Top-ranked sequences
organism | matching |
---|---|
Homo sapiens | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQWFT 55 |||||||||||||||||||||||||#|||||||||||||||||||||||||||||| Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQWFT 55 |
N/A | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQWFT 55 |||||||||||||||||||||||||#|||||||||||||||||||||||||||||| Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQWFT 55 |
Pan troglodytes | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQWFT 55 |||||||||||||||||||||||||#|||||||||||||||||||||||||||||| Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQWFT 55 |
synthetic construct | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQWFT 55 |||||||||||||||||||||||||#|||||||||||||||||||||||||||||| Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQWFT 55 |
Tupaia belangeri chinensis | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQWFT 55 |||||||||||||||||||||||||#|||||||||||||||||||||||||||||| Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQWFT 55 |
Macaca mulatta | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQWFT 55 |||||||||+|||||||||||||||#||||||||||||||+|||||||||+ || | Sbjct 1 MEEPQSDPSIEPPLSQETFSDLWKL#LPENNVLSPLPSQAVDDLMLSPDDLAQWLT 55 |
Chlorocebus aethiops | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQWFT 55 |||||||||+|||||||||||||||#||||||||||||||+|||||||||+ || | Sbjct 1 MEEPQSDPSIEPPLSQETFSDLWKL#LPENNVLSPLPSQAVDDLMLSPDDLAQWLT 55 |
Macaca fascicularis | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQWFT 55 |||||||||+|||||||||||||||#||||+|||||||||+|||||||||+ || | Sbjct 1 MEEPQSDPSIEPPLSQETFSDLWKL#LPENHVLSPLPSQAVDDLMLSPDDLAQWLT 55 |
Marmota monax | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQWF 54 ||| ||| |+||||||||||||| |#|||||||||+ | ||||+|| +|+| || Sbjct 1 MEEAQSDLSIEPPLSQETFSDLWNL#LPENNVLSPVLSPPMDDLLLSSEDVENWF 54 |
Spalax judaei | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLS-PLPSQAMDDLMLSPDDIEQW 53 ||| ||| |+|||||||||||||||#||+||||| || +|+||+|||+|+ | Sbjct 1 MEEQQSDLSIEPPLSQETFSDLWKL#LPQNNVLSTPLSPNSMEDLLLSPEDVANW 54 |
Cavia porcellus | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQW 53 |||| || |+|||||||||||||||#|||||||| | || |+|||+++ | Sbjct 1 MEEPHSDLSIEPPLSQETFSDLWKL#LPENNVLSDSLSPPMDHLLLSPEEVASW 53 |
Delphinapterus leucas | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQW 53 ||| |++ ||||||||||||||||#|||||+|| | |+|||+|||+|+ | Sbjct 1 MEESQAELGVEPPLSQETFSDLWKL#LPENNLLSSELSPAVDDLLLSPEDVANW 53 |
Meriones unguiculatus | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQW 53 ||||||| |+|||||||||||||||#|| |+|| | + |+||+| | |+ | Sbjct 1 MEEPQSDLSIEPPLSQETFSDLWKL#LPPKNLLSAL--EPMEDLLL-PQDVTSW 50 |
Oryctolagus cuniculus | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQW 53 ||| ||| |+|||||||||||||||#|||||+|+ + +||| || +|+ | Sbjct 1 MEESQSDLSLEPPLSQETFSDLWKL#LPENNLLTTSLNPPVDDL-LSAEDVANW 52 |
Cricetulus griseus | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLP-SQAMDDLMLSPDDIEQW 53 ||||||| |+| |||||||||||||#|| ||||| || | ++++| || +++ | Sbjct 1 MEEPQSDLSIELPLSQETFSDLWKL#LPPNNVLSTLPSSDSIEELFLS-ENVTGW 53 |
Mesocricetus auratus | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLP-SQAMDDLMLSPDDIEQW 53 ||||||| |+| |||||||||||||#|| ||||| || | ++++| || +++ | Sbjct 1 MEEPQSDLSIELPLSQETFSDLWKL#LPPNNVLSTLPSSDSIEELFLS-ENVAGW 53 |
Sus scrofa | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVL-SPLPSQAMDDLMLSP 47 ||| ||+ ||||||||||||||||#|||||+| | | |++||+||| Sbjct 1 MEESQSELGVEPPLSQETFSDLWKL#LPENNLLSSELSLAAVNDLLLSP 48 |
Ovis aries | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQW 53 ||| |++ |||||||||||||| |#|||||+|| | +|||+ +|+ | Sbjct 1 MEESQAELGVEPPLSQETFSDLWNL#LPENNLLSSELSAPVDDLLPYSEDVVTW 53 |
Canis familiaris | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQW 53 |+||||+ +++|||||||||+|| |#|||||||| |+|+|+| |+ + | Sbjct 1 MQEPQSELNIDPPLSQETFSELWNL#LPENNVLSSELCPAVDELLL-PESVVNW 52 |
Felis catus | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQW 53 |+|| + ++||||||||||+|| |#|||||||| | ||++| || +|+ | Sbjct 1 MQEPPLELTIEPPLSQETFSELWNL#LPENNVLSSELSSAMNELPLS-EDVANW 52 |
Canis lupus familiaris | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQW 53 ||| ||+ +++|||||||||+|| |#|||||||| |+|+|+| |+ + | Sbjct 1 MEESQSELNIDPPLSQETFSELWNL#LPENNVLSSELCPAVDELLL-PESVVNW 52 |
Bos taurus | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQW 53 ||| |++ +|||||||||||||| |#|||||+|| | +||| | |+ | Sbjct 1 MEESQAELNVEPPLSQETFSDLWNL#LPENNLLSSELSAPVDDL-LPYTDVATW 52 |
Mus musculus | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQWF 54 ||| ||| |+| |||||||| ||||#|| ++|| ||||+| | |+|++| Sbjct 4 MEESQSDISLELPLSQETFSGLWKL#LPPEDILS--SPHCMDDLLL-PQDVEEFF 54 |
Rattus norvegicus | Query 1 MEEPQSDPSVEPPLSQETFSDLWKL#LPENNVLSPLPS---QAMDDLMLSPDDIE 51 ||+ ||| |+| |||||||| ||||#|| +++| + +|+|| | | | Sbjct 1 MEDSQSDMSIELPLSQETFSCLWKL#LPPDDILPTTATGSPNSMEDLFLPQDVAE 54 |
Bos primigenius | Query 13 PLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPDDIEQW 53 ||||||||||| |#|||||+|| | +||| | |+ | Sbjct 1 PLSQETFSDLWNL#LPENNLLSSELSAPVDDL-LPYTDVATW 40 |
Mastomys natalensis | Query 13 PLSQETFSDLWKL#LPENNVLSPLPSQAMDDLMLSPD 48 ||||||| ||||#|| ||| +||++ |||| Sbjct 2 PLSQETFQRLWKL#LPPEAVLSEASPNSMDNMFLSPD 37 |
Xenopus tropicalis | Query 3 EPQSDPSVEPPLSQETFSDLWKL#LPE 28 || |+ +||||||||| ||| |#||+ Sbjct 2 EPSSETGMEPPLSQETFEDLWSL#LPD 27 |
Xenopus laevis | Query 3 EPQSDPSVEPPLSQETFSDLWKL#LPE 28 || |+ ++|||||||| ||| |#||+ Sbjct 2 EPSSETGMDPPLSQETFEDLWSL#LPD 27 |
* References
[PubMed ID: 4006916] Zakut-Houri R, Bienz-Tadmor B, Givol D, Oren M, Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells. EMBO J. 1985 May;4(5):1251-5.
[PubMed ID: 2946935] ... Lamb P, Crawford L, Characterization of the human p53 gene. Mol Cell Biol. 1986 May;6(5):1379-85.
[PubMed ID: 3894933] ... Harlow E, Williamson NM, Ralston R, Helfman DM, Adams TE, Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53. Mol Cell Biol. 1985 Jul;5(7):1601-10.
[PubMed ID: 3025664] ... Harris N, Brill E, Shohat O, Prokocimer M, Wolf D, Arai N, Rotter V, Molecular basis for heterogeneity of the human p53 protein. Mol Cell Biol. 1986 Dec;6(12):4650-6.
[PubMed ID: 2905688] ... Buchman VL, Chumakov PM, Ninkina NN, Samarina OP, Georgiev GP, A variation in the structure of the protein-coding region of the human p53 gene. Gene. 1988 Oct 30;70(2):245-52.
[PubMed ID: 6396087] ... Matlashewski G, Lamb P, Pim D, Peacock J, Crawford L, Benchimol S, Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene. EMBO J. 1984 Dec 20;3(13):3257-62.
[PubMed ID: 1915267] ... Farrell PJ, Allan GJ, Shanahan F, Vousden KH, Crook T, p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO J. 1991 Oct;10(10):2879-87.
[PubMed ID: 8316628] ... Allalunis-Turner MJ, Barron GM, Day RS 3rd, Dobler KD, Mirzayans R, Isolation of two cell lines from a human malignant glioma specimen differing in sensitivity to radiation and chemotherapeutic drugs. Radiat Res. 1993 Jun;134(3):349-54.
[PubMed ID: 11058590] ... Chang NS, Pratt N, Heath J, Schultz L, Sleve D, Carey GB, Zevotek N, Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity. J Biol Chem. 2001 Feb 2;276(5):3361-70. Epub 2000 Oct 31.
[PubMed ID: 11023613] ... Anderson CW, Allalunis-Turner MJ, Human TP53 from the malignant glioma-derived cell lines M059J and M059K has a cancer-associated mutation in exon 8. Radiat Res. 2000 Oct;154(4):473-6.
[PubMed ID: 15489334] ... Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J, The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
[PubMed ID: 14660794] ... Kanashiro CA, Schally AV, Groot K, Armatis P, Bernardino AL, Varga JL, Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15836-41. Epub 2003 Dec 5.
[PubMed ID: 2156209] ... Addison C, Jenkins JR, Sturzbecher HW, The p53 nuclear localisation signal is structurally linked to a p34cdc2 kinase motif. Oncogene. 1990 Mar;5(3):423-6.
[PubMed ID: 2141171] ... Bischoff JR, Friedman PN, Marshak DR, Prives C, Beach D, Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4766-70.
[PubMed ID: 1705009] ... Samad A, Carroll RB, The tumor suppressor p53 is bound to RNA by a stable covalent linkage. Mol Cell Biol. 1991 Mar;11(3):1598-606.
[PubMed ID: 1848668] ... Scheidtmann KH, Mumby MC, Rundell K, Walter G, Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small-t antigen. Mol Cell Biol. 1991 Apr;11(4):1996-2003.
[PubMed ID: 8632903] ... Flaman JM, Waridel F, Estreicher A, Vannier A, Limacher JM, Gilbert D, Iggo R, Frebourg T, The human tumour suppressor gene p53 is alternatively spliced in normal cells. Oncogene. 1996 Feb 15;12(4):813-8.
[PubMed ID: 8632915] ... Shaw P, Freeman J, Bovey R, Iggo R, Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. Oncogene. 1996 Feb 15;12(4):921-30.
[PubMed ID: 10562558] ... Gostissa M, Hengstermann A, Fogal V, Sandy P, Schwarz SE, Scheffner M, Del Sal G, Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J. 1999 Nov 15;18(22):6462-71.
[PubMed ID: 10656795] ... Abraham J, Kelly J, Thibault P, Benchimol S, Post-translational modification of p53 protein in response to ionizing radiation analyzed by mass spectrometry. J Mol Biol. 2000 Jan 28;295(4):853-64.
[PubMed ID: 10644996] ... Sandy P, Gostissa M, Fogal V, Cecco LD, Szalay K, Rooney RJ, Schneider C, Del Sal G, p53 is involved in the p120E4F-mediated growth arrest. Oncogene. 2000 Jan 13;19(2):188-99.
[PubMed ID: 10951572] ... Lopez-Borges S, Lazo PA, The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein. Oncogene. 2000 Jul 27;19(32):3656-64.
[PubMed ID: 11554448] ... Hainaut P, Mann K, Zinc binding and redox control of p53 structure and function. Antioxid Redox Signal. 2001 Aug;3(4):611-23.
[PubMed ID: 11672523] ... Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA, hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. 2001 Oct 19;107(2):149-59.
[PubMed ID: 11007800] ... Hong TM, Chen JJ, Peck K, Yang PC, Wu CW, p53 amino acids 339-346 represent the minimal p53 repression domain. J Biol Chem. 2001 Jan 12;276(2):1510-5.
[PubMed ID: 11124955] ... Rodriguez MS, Dargemont C, Hay RT, SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J Biol Chem. 2001 Apr 20;276(16):12654-9. Epub 2000 Dec 21.
[PubMed ID: 11546806] ... Abe Y, Matsumoto S, Wei S, Nezu K, Miyoshi A, Kito K, Ueda N, Shigemoto K, Hitsumoto Y, Nikawa J, Enomoto Y, Cloning and characterization of a p53-related protein kinase expressed in interleukin-2-activated cytotoxic T-cells, epithelial tumor cell lines, and the testes. J Biol Chem. 2001 Nov 23;276(47):44003-11. Epub 2001 Sep 6.
[PubMed ID: 11239457] ... Keller DM, Zeng X, Wang Y, Zhang QH, Kapoor M, Shu H, Goodman R, Lozano G, Zhao Y, Lu H, A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1. Mol Cell. 2001 Feb;7(2):283-92.
[PubMed ID: 12507430] ... Hu M, Li P, Li M, Li W, Yao T, Wu JW, Gu W, Cohen RE, Shi Y, Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell. 2002 Dec 27;111(7):1041-54.
[PubMed ID: 11706030] ... Tsuji K, Mizumoto K, Yamochi T, Nishimoto I, Matsuoka M, Differential effect of ik3-1/cables on p53- and p73-induced cell death. J Biol Chem. 2002 Jan 25;277(4):2951-7. Epub 2001 Nov 12.
[PubMed ID: 11925430] ... Kim EJ, Park JS, Um SJ, Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo. J Biol Chem. 2002 Aug 30;277(35):32020-8. Epub 2002 Mar 29.
[PubMed ID: 11740489] ... Hofmann TG, Moller A, Sirma H, Zentgraf H, Taya Y, Droge W, Will H, Schmitz ML, Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol. 2002 Jan;4(1):1-10.
[PubMed ID: 11780126] ... D'Orazi G, Cecchinelli B, Bruno T, Manni I, Higashimoto Y, Saito S, Gostissa M, Coen S, Marchetti A, Del Sal G, Piaggio G, Fanciulli M, Appella E, Soddu S, Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol. 2002 Jan;4(1):11-9.
[PubMed ID: 12750254] ... Shiseki M, Nagashima M, Pedeux RM, Kitahama-Shiseki M, Miura K, Okamura S, Onogi H, Higashimoto Y, Appella E, Yokota J, Harris CC, p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res. 2003 May 15;63(10):2373-8.
[PubMed ID: 12724314] ... Wang YH, Tsay YG, Tan BC, Lo WY, Lee SC, Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305. J Biol Chem. 2003 Jul 11;278(28):25568-76. Epub 2003 Apr 30.
[PubMed ID: 12851404] ... Tomasini R, Samir AA, Carrier A, Isnardon D, Cecchinelli B, Soddu S, Malissen B, Dagorn JC, Iovanna JL, Dusetti NJ, TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity. J Biol Chem. 2003 Sep 26;278(39):37722-9. Epub 2003 Jul 7.
[PubMed ID: 12944468] ... O'Keefe K, Li H, Zhang Y, Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination. Mol Cell Biol. 2003 Sep;23(18):6396-405.
[PubMed ID: 12702766] ... Kondo S, Lu Y, Debbas M, Lin AW, Sarosi I, Itie A, Wakeham A, Tuan J, Saris C, Elliott G, Ma W, Benchimol S, Lowe SW, Mak TW, Thukral SK, Characterization of cells and gene-targeted mice deficient for the p53-binding kinase homeodomain-interacting protein kinase 1 (HIPK1). Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5431-6. Epub 2003 Apr 17.
[PubMed ID: 15109303] ... Hasan MK, Yaguchi T, Minoda Y, Hirano T, Taira K, Wadhwa R, Kaul SC, Alternative reading frame protein (ARF)-independent function of CARF (collaborator of ARF) involves its interactions with p53: evidence for a novel p53-activation pathway and its negative feedback control. Biochem J. 2004 Jun 15;380(Pt 3):605-10.
[PubMed ID: 15186775] ... An W, Kim J, Roeder RG, Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell. 2004 Jun 11;117(6):735-48.
[PubMed ID: 15053879] ... Li HH, Li AG, Sheppard HM, Liu X, Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression. Mol Cell. 2004 Mar 26;13(6):867-78.
[PubMed ID: 15525938] ... Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, Ivanov GS, McKinney K, Tempst P, Prives C, Gamblin SJ, Barlev NA, Reinberg D, Regulation of p53 activity through lysine methylation. Nature. 2004 Nov 18;432(7015):353-60. Epub 2004 Nov 3.
[PubMed ID: 15701641] ... Jalota A, Singh K, Pavithra L, Kaul-Ghanekar R, Jameel S, Chattopadhyay S, Tumor suppressor SMAR1 activates and stabilizes p53 through its arginine-serine-rich motif. J Biol Chem. 2005 Apr 22;280(16):16019-29. Epub 2005 Feb 8.
[PubMed ID: 16219768] ... Chang NS, Doherty J, Ensign A, Schultz L, Hsu LJ, Hong Q, WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53. J Biol Chem. 2005 Dec 30;280(52):43100-8. Epub 2005 Oct 11.
[PubMed ID: 16083285] ... Kim JE, Tannenbaum SR, White FM, Global phosphoproteome of HT-29 human colon adenocarcinoma cells. J Proteome Res. 2005 Jul-Aug;4(4):1339-46.
[PubMed ID: 16376338] ... Gu YM, Jin YH, Choi JK, Baek KH, Yeo CY, Lee KY, Protein kinase A phosphorylates and regulates dimerization of 14-3-3 epsilon. FEBS Lett. 2006 Jan 9;580(1):305-10. Epub 2005 Dec 19.
[PubMed ID: 17108971] ... Huang J, Perez-Burgos L, Placek BJ, Sengupta R, Richter M, Dorsey JA, Kubicek S, Opravil S, Jenuwein T, Berger SL, Repression of p53 activity by Smyd2-mediated methylation. Nature. 2006 Nov 30;444(7119):629-32. Epub 2006 Nov 15.
[PubMed ID: 16415881] ... Couture JF, Collazo E, Hauk G, Trievel RC, Structural basis for the methylation site specificity of SET7/9. Nat Struct Mol Biol. 2006 Feb;13(2):140-6. Epub 2006 Jan 15.
[PubMed ID: 17170702] ... Yamasaki S, Yagishita N, Sasaki T, Nakazawa M, Kato Y, Yamadera T, Bae E, Toriyama S, Ikeda R, Zhang L, Fujitani K, Yoo E, Tsuchimochi K, Ohta T, Araya N, Fujita H, Aratani S, Eguchi K, Komiya S, Maruyama I, Higashi N, Sato M, Senoo H, Ochi T, Yokoyama S, Amano T, Kim J, Gay S, Fukamizu A, Nishioka K, Tanaka K, Nakajima T, Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase 'Synoviolin'. EMBO J. 2007 Jan 10;26(1):113-22. Epub 2006 Dec 14.
[PubMed ID: 17904127] ... Zhou X, Yang G, Huang R, Chen X, Hu G, SVH-B interacts directly with p53 and suppresses the transcriptional activity of p53. FEBS Lett. 2007 Oct 16;581(25):4943-8. Epub 2007 Sep 21.
[PubMed ID: 18022393] ... Arai S, Matsushita A, Du K, Yagi K, Okazaki Y, Kurokawa R, Novel homeodomain-interacting protein kinase family member, HIPK4, phosphorylates human p53 at serine 9. FEBS Lett. 2007 Dec 11;581(29):5649-57. Epub 2007 Nov 20.
[PubMed ID: 17317671] ... Zhao Y, Katzman RB, Delmolino LM, Bhat I, Zhang Y, Gurumurthy CB, Germaniuk-Kurowska A, Reddi HV, Solomon A, Zeng MS, Kung A, Ma H, Gao Q, Dimri G, Stanculescu A, Miele L, Wu L, Griffin JD, Wazer DE, Band H, Band V, The notch regulator MAML1 interacts with p53 and functions as a coactivator. J Biol Chem. 2007 Apr 20;282(16):11969-81. Epub 2007 Feb 22.
[PubMed ID: 17805299] ... Huang J, Sengupta R, Espejo AB, Lee MG, Dorsey JA, Richter M, Opravil S, Shiekhattar R, Bedford MT, Jenuwein T, Berger SL, p53 is regulated by the lysine demethylase LSD1. Nature. 2007 Sep 6;449(7158):105-8.
[PubMed ID: 17287340] ... Molina H, Horn DM, Tang N, Mathivanan S, Pandey A, Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry. Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2199-204. Epub 2007 Feb 7.
[PubMed ID: 17525332] ... Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER 3rd, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, Elledge SJ, ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science. 2007 May 25;316(5828):1160-6.
[PubMed ID: 8023159] ... Clore GM, Omichinski JG, Sakaguchi K, Zambrano N, Sakamoto H, Appella E, Gronenborn AM, High-resolution structure of the oligomerization domain of p53 by multidimensional NMR. Science. 1994 Jul 15;265(5170):386-91.
[PubMed ID: 7773777] ... Lee W, Harvey TS, Yin Y, Yau P, Litchfield D, Arrowsmith CH, Solution structure of the tetrameric minimum transforming domain of p53. Nat Struct Biol. 1994 Dec;1(12):877-90.
[PubMed ID: 9321402] ... McCoy M, Stavridi ES, Waterman JL, Wieczorek AM, Opella SJ, Halazonetis TD, Hydrophobic side-chain size is a determinant of the three-dimensional structure of the p53 oligomerization domain. EMBO J. 1997 Oct 15;16(20):6230-6.
[PubMed ID: 8023157] ... Cho Y, Gorina S, Jeffrey PD, Pavletich NP, Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science. 1994 Jul 15;265(5170):346-55.
[PubMed ID: 7878469] ... Jeffrey PD, Gorina S, Pavletich NP, Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science. 1995 Mar 10;267(5203):1498-502.
[PubMed ID: 8875929] ... Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, Pavletich NP, Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science. 1996 Nov 8;274(5289):948-53.
[PubMed ID: 8875926] ... Gorina S, Pavletich NP, Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science. 1996 Nov 8;274(5289):1001-5.
[PubMed ID: 16474402] ... Sheng Y, Saridakis V, Sarkari F, Duan S, Wu T, Arrowsmith CH, Frappier L, Molecular recognition of p53 and MDM2 by USP7/HAUSP. Nat Struct Mol Biol. 2006 Mar;13(3):285-91. Epub 2006 Feb 12.
[PubMed ID: 16402859] ... Hu M, Gu L, Li M, Jeffrey PD, Gu W, Shi Y, Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway. PLoS Biol. 2006 Feb;4(2):e27. Epub 2006 Jan 17.
[PubMed ID: 8266092] ... Harris CC, p53: at the crossroads of molecular carcinogenesis and risk assessment. Science. 1993 Dec 24;262(5142):1980-1.
[PubMed ID: 1905840] ... Hollstein M, Sidransky D, Vogelstein B, Harris CC, p53 mutations in human cancers. Science. 1991 Jul 5;253(5015):49-53.
[PubMed ID: 8829653] ... De Vries EM, Ricke DO, De Vries TN, Hartmann A, Blaszyk H, Liao D, Soussi T, Kovach JS, Sommer SS, Database of mutations in the p53 and APC tumor suppressor genes designed to facilitate molecular epidemiological analyses. Hum Mutat. 1996;7(3):202-13.
[PubMed ID: 1999338] ... Olschwang S, Laurent-Puig P, Vassal A, Salmon RJ, Thomas G, Characterization of a frequent polymorphism in the coding sequence of the Tp53 gene in colonic cancer patients and a control population. Hum Genet. 1991 Feb;86(4):369-70.
[PubMed ID: 1933902] ... Law JC, Strong LC, Chidambaram A, Ferrell RE, A germ line mutation in exon 5 of the p53 gene in an extended cancer family. Cancer Res. 1991 Dec 1;51(23 Pt 1):6385-7.
[PubMed ID: 1978757] ... Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, et al., Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990 Nov 30;250(4985):1233-8.
[PubMed ID: 2259385] ... Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH, Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature. 1990 Dec 20-27;348(6303):747-9.
[PubMed ID: 1737852] ... Felix CA, Nau MM, Takahashi T, Mitsudomi T, Chiba I, Poplack DG, Reaman GH, Cole DE, Letterio JJ, Whang-Peng J, et al., Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia. J Clin Invest. 1992 Feb;89(2):640-7.
[PubMed ID: 1565144] ... Malkin D, Jolly KW, Barbier N, Look AT, Friend SH, Gebhardt MC, Andersen TI, Borresen AL, Li FP, Garber J, et al., Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med. 1992 May 14;326(20):1309-15.
[PubMed ID: 1694291] ... Bartek J, Iggo R, Gannon J, Lane DP, Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene. 1990 Jun;5(6):893-9.
[PubMed ID: 1699228] ... Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, Lane DP, p53 mutations in colorectal cancer. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7555-9.
[PubMed ID: 2263646] ... Hollstein MC, Metcalf RA, Welsh JA, Montesano R, Harris CC, Frequent mutation of the p53 gene in human esophageal cancer. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9958-61.
[PubMed ID: 1647768] ... Ishioka C, Sato T, Gamoh M, Suzuki T, Shibata H, Kanamaru R, Wakui A, Yamazaki T, Mutations of the P53 gene, including an intronic point mutation, in colorectal tumors. Biochem Biophys Res Commun. 1991 Jun 28;177(3):901-6.
[PubMed ID: 1868473] ... Casson AG, Mukhopadhyay T, Cleary KR, Ro JY, Levin B, Roth JA, p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res. 1991 Aug 15;51(16):4495-9.
[PubMed ID: 1849234] ... Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC, Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature. 1991 Apr 4;350(6317):427-8.
[PubMed ID: 1672732] ... Bressac B, Kew M, Wands J, Ozturk M, Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature. 1991 Apr 4;350(6317):429-31.
[PubMed ID: 1394225] ... Somers KD, Merrick MA, Lopez ME, Incognito LS, Schechter GL, Casey G, Frequent p53 mutations in head and neck cancer. Cancer Res. 1992 Nov 1;52(21):5997-6000.
[PubMed ID: 1327751] ... Crook T, Vousden KH, Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens. EMBO J. 1992 Nov;11(11):3935-40.
[PubMed ID: 1459726] ... Sakai E, Rikimaru K, Ueda M, Matsumoto Y, Ishii N, Enomoto S, Yamamoto H, Tsuchida N, The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma. Int J Cancer. 1992 Dec 2;52(6):867-72.
[PubMed ID: 1303181] ... Bhatia K, Gutierrez MI, Magrath IT, A novel mutation in the p53 gene in a Burkitt's lymphoma cell line. Hum Mol Genet. 1992 Jun;1(3):207-8.
[PubMed ID: 1437144] ... Duthu A, Debuire B, Romano J, Ehrhart JC, Fiscella M, May E, Appella E, May P, p53 mutations in Raji cells: characterization and localization relative to other Burkitt's lymphomas. Oncogene. 1992 Nov;7(11):2161-7.
[PubMed ID: 1631151] ... Sun Y, Hegamyer G, Cheng YJ, Hildesheim A, Chen JY, Chen IH, Cao Y, Yao KT, Colburn NH, An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6516-20.
[PubMed ID: 7682763] ... Caamano J, Zhang SY, Rosvold EA, Bauer B, Klein-Szanto AJ, p53 alterations in human squamous cell carcinomas and carcinoma cell lines. Am J Pathol. 1993 Apr;142(4):1131-9.
[PubMed ID: 8402617] ... Boyle JO, Hakim J, Koch W, van der Riet P, Hruban RH, Roa RA, Correo R, Eby YJ, Ruppert JM, Sidransky D, The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. 1993 Oct 1;53(19):4477-80.
[PubMed ID: 8336944] ... Hamelin R, Jego N, Laurent-Puig P, Vidaud M, Thomas G, Efficient screening of p53 mutations by denaturing gradient gel electrophoresis in colorectal tumors. Oncogene. 1993 Aug;8(8):2213-20.
[PubMed ID: 8118819] ... Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Jones PH, Binchy A, Crowther D, et al., Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res. 1994 Mar 1;54(5):1298-304.
[PubMed ID: 8013454] ... Zhang W, Guo XY, Hu GY, Liu WB, Shay JW, Deisseroth AB, A temperature-sensitive mutant of human p53. EMBO J. 1994 Jun 1;13(11):2535-44.
[PubMed ID: 7887414] ... Frebourg T, Barbier N, Yan YX, Garber JE, Dreyfus M, Fraumeni J Jr, Li FP, Friend SH, Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet. 1995 Mar;56(3):608-15.
[PubMed ID: 8718514] ... Eeles RA, Germline mutations in the TP53 gene. Cancer Surv. 1995;25:101-24.
[PubMed ID: 8825920] ... Varley JM, McGown G, Thorncroft M, Tricker KJ, Teare MD, Santibanez-Koref MF, Martin J, Birch JM, Evans DG, An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53. J Med Genet. 1995 Dec;32(12):942-5.
[PubMed ID: 8829627] ... Audrezet MP, Robaszkiewicz M, Mercier B, Nousbaum JB, Hardy E, Bail JP, Volant A, Lozac'h P, Gouerou H, Ferec C, Molecular analysis of the TP53 gene in Barrett's adenocarcinoma. Hum Mutat. 1996;7(2):109-13.
[PubMed ID: 9101296] ... Guldberg P, Nedergaard T, Nielsen HJ, Olsen AC, Ahrenkiel V, Zeuthen J, Single-step DGGE-based mutation scanning of the p53 gene: application to genetic diagnosis of colorectal cancer. Hum Mutat. 1997;9(4):348-55.
[PubMed ID: 9419979] ... Miyaki M, Nishio J, Konishi M, Kikuchi-Yanoshita R, Tanaka K, Muraoka M, Nagato M, Chong JM, Koike M, Terada T, Kawahara Y, Fukutome A, Tomiyama J, Chuganji Y, Momoi M, Utsunomiya J, Drastic genetic instability of tumors and normal tissues in Turcot syndrome. Oncogene. 1997 Dec 4;15(23):2877-81.
[PubMed ID: 9450901] ... van Rensburg EJ, Engelbrecht S, van Heerden WF, Kotze MJ, Raubenheimer EJ, Detection of p53 gene mutations in oral squamous cell carcinomas of a black African population sample. Hum Mutat. 1998;11(1):39-44.
[PubMed ID: 9452042] ... Luca JW, Strong LC, Hansen MF, A germline missense mutation R337C in exon 10 of the human p53 gene. Hum Mutat. 1998;Suppl 1:S58-61.
[PubMed ID: 10484981] ... Guran S, Tunca Y, Imirzalioglu N, Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family. Cancer Genet Cytogenet. 1999 Sep;113(2):145-51.
[PubMed ID: 10549356] ... Hainaut P, Hollstein M, p53 and human cancer: the first ten thousand mutations. Adv Cancer Res. 2000;77:81-137.
[PubMed ID: 11481490] ... Ribeiro RC, Sandrini F, Figueiredo B, Zambetti GP, Michalkiewicz E, Lafferty AR, DeLacerda L, Rabin M, Cadwell C, Sampaio G, Cat I, Stratakis CA, Sandrini R, An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9330-5.
[PubMed ID: 12085209] ... Rutherford J, Chu CE, Duddy PM, Charlton RS, Chumas P, Taylor GR, Lu X, Barnes DM, Camplejohn RS, Investigations on a clinically and functionally unusual and novel germline p53 mutation. Br J Cancer. 2002 May 20;86(10):1592-6.
[PubMed ID: 16959974] ... Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE, The consensus coding sequences of human breast and colorectal cancers. Science. 2006 Oct 13;314(5797):268-74. Epub 2006 Sep 7.
[PubMed ID: 17224074] ... Chanock SJ, Burdett L, Yeager M, Llaca V, Langerod A, Presswalla S, Kaaresen R, Strausberg RL, Gerhard DS, Kristensen V, Perou CM, Borresen-Dale AL, Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas. Breast Cancer Res. 2007;9(1):R5.
[PubMed ID: 17311302] ... Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, Olivier M, Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat. 2007 Jun;28(6):622-9.